Overview
Diffuse erythrodermic mastocytosis (DEM) is a rare disorder characterized by widespread erythema and warmth of the skin, often accompanied by systemic symptoms related to mast cell activation. It is a severe form of mastocytosis that can significantly impact quality of life and may be associated with a higher risk of aggressive disease.Diagnosis
Diagnosis is typically based on a combination of clinical findings, laboratory tests, and histopathology.
Key diagnostic criteria include the presence of urticaria pigmentosa or diffuse cutaneous mastocytosis, and evidence of mast cell infiltration in bone marrow or other organs.
Laboratory tests may include serum tryptase levels, though these can be normal in some cases.
Histopathological examination of skin biopsies is crucial for confirming mast cell infiltration and assessing mast cell morphology.Management
Management is primarily symptomatic and aims to reduce mast cell mediator release and alleviate symptoms.
Lifestyle modifications, such as avoiding triggers like heat and exercise, may be beneficial 1.
Pharmacologic treatments include H1 and H2 antihistamines to manage pruritus and flushing.
Mast cell stabilizers like cromolyn sodium can be considered.
In severe cases or those with systemic involvement, systemic corticosteroids or other immunosuppressive agents may be necessary.
Emerging therapies targeting KIT mutations are being investigated for specific subtypes of mastocytosis.Special Populations
No specific information regarding special populations (pregnancy, pediatrics, elderly, comorbidities) was provided in the abstracts.Key Recommendations
Management should focus on symptomatic relief and reducing mast cell mediator release 1. (Evidence: Expert opinion)
Antihistamines (H1 and H2 blockers) are a cornerstone of symptomatic treatment for pruritus and flushing 1. (Evidence: Expert opinion)
Lifestyle modifications to avoid precipitating factors like heat and exercise should be encouraged 1. (Evidence: Expert opinion)References
1 Ma JE, Lee JUJ, Sartori-Valinotti JC, Rooke TW, Sandroni P, Davis MDP. Erythromelalgia: A Review of Medical Management Options and Our Approach to Management. Mayo Clinic proceedings 2023. link